Immunocore files to sell 69,271 ADRs

Immunocore Holdings Plc reports a proposed sale of 69,271 ADRs by means of a same-day cashless exercise and sale scheduled for 05/26/2026 with cash settlement.

Rhea-AI Filing Summary

Immunocore Holdings Plc reports a proposed sale of 69,271 ADRs by means of a same-day cashless exercise and sale scheduled for 05/26/2026 with cash settlement. The filing lists recent sales by David Berman: 11,832 ADRs on 03/11/2026 for $385,330.11, 25,000 ADRs on 04/08/2026 for $798,510.57, and 65,000 ADRs on 05/21/2026 for $1,894,638.32.

Key Figures

ADRs to be sold: 69,271 ADRs Prior sale 03/11/2026: 11,832 ADRs Prior sale 04/08/2026: 25,000 ADRs +3 more

6 metrics

ADRs to be sold 69,271 ADRs same-day cashless exercise and sale scheduled 05/26/2026

Prior sale 03/11/2026 11,832 ADRs proceeds $385,330.11

Prior sale 04/08/2026 25,000 ADRs proceeds $798,510.57

Prior sale 05/21/2026 65,000 ADRs proceeds $1,894,638.32

Settlement date 05/26/2026 cash settlement via same-day cashless exercise

Broker J.P. Morgan Securities LLC listed as the broker handling the sale

Key Terms

Form 144, ADR, Same Day Cashless Exercise, Cash settlement

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

ADR financial

"144: Securities Sold During The Past 3 Months"

An American Depositary Receipt (ADR) is a financial certificate that lets investors buy shares of a foreign company through U.S. stock markets, similar to buying a local wrapper that represents the underlying foreign shares. ADRs matter because they make investing in overseas companies easier and more liquid by trading in U.S. dollars and under U.S. market rules, while still carrying currency, regulatory, and country-specific risks that can affect share value.

Same Day Cashless Exercise financial

"Same Day Cashless Exercise and Sale"

Cash settlement financial

"05/26/2026 | Cash"

Cash settlement is a process where, instead of exchanging physical assets like stocks or commodities, the parties involved settle the difference in value with money after a contract ends. For investors, it simplifies transactions by avoiding the need to handle or deliver the actual asset, making it quicker and more convenient to complete trades. This method ensures a straightforward way to settle agreements based on their final value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IMCR's Form 144 report?

It reports a proposed sale of 69,271 ADRs via a same-day cashless exercise and sale scheduled for 05/26/2026. The filing identifies the broker as J.P. Morgan Securities LLC and indicates cash settlement.

Who executed recent sales reported in the filing for IMCR?

The filing lists prior sales by David Berman: 11,832 ADRs on 03/11/2026 for $385,330.11, 25,000 ADRs on 04/08/2026 for $798,510.57, and 65,000 ADRs on 05/21/2026 for $1,894,638.32.

What sale method is stated in the IMCR Form 144?

The Form 144 specifies a Same Day Cashless Exercise and Sale to be effected through J.P. Morgan Securities LLC on 05/26/2026, with proceeds described as cash settlement in the excerpt.

Does the filing state how many ADRs were to be sold by the issuer or underwriters?

The filing identifies 69,271 ADRs as the securities to be sold via the same-day cashless exercise. The excerpt does not describe any additional issuer or underwriter offer quantities beyond that line.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 03:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001955244
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Immunocore Holdings PLC
SEC File Number
Address of Issuer	92 Park Drive Milton Park Oxfordshire UNITED KINGDOM OX14 4 RY
Phone	441235438600
Name of Person for Whose Account the Securities are To Be Sold	David Berman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ADR	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	69271	2042147.94	50387068	05/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADR	05/22/2026	Same Day Cashless Exercise and Sale	Immunocore Holdings Plc (issuer)			69271	05/26/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Berman 4915 Hampden Ln Unit 405 Bethesda MD 20814	ADR	03/11/2026	11832	385330.11
David Berman 4915 Hampden Ln Unit 405 Bethesda MD 20814	ADR	04/08/2026	25000	798510.57
David Berman 4915 Hampden Ln Unit 405 Bethesda MD 20814	ADR	05/21/2026	65000	1894638.32

144: Remarks and Signature

Remarks
Date of Notice	05/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for David Berman, Immunocore Holdings PLC
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)